Philip Morris
Characterization of A Purified Nicotinic Receptor From Rat Brain Using Idiotypic and Anti-Idiotypic Antibodies
Fields
- Author
- Abood, L.G.
- Banerjee, S.
- Bjercke, R.
- Langone, J.J.
- Xin, L.
- Banerjee, S.
- Area
- CENTRAL FILES/PRE-DB WAREHOUSE
- Type
- SCRT, REPORT, SCIENTIFIC
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- ABST, ABSTRACT
- Site
- R107
- Request
- Stmn/R1-147
- Stmn/R2-035
- Named Organization
- Mcneil Pharmaceutical
- New England Nuclear
- Pnas
- Bio Rad Lab
- Ctr, Council for Tobacco Research
- New England Nuclear
- Named Person
- Favre
- Itokawa
- Laemmli
- Lindstrom
- Seeman, J.
- Towbin
- Whiting
- Itokawa
- Document File
- 2021576679/2021576983a/Missing
- 2021576680/2021576983/870000
- Litigation
- Stmn/Produced
- Author (Organization)
- Baylor
- Univ of Rochester
- Master ID
- 2021576754/6831
Related Documents:- 2021576754-6762 Solubilization and Purification of the Ni-Stimulated Arginine-Vasopressin Binding Site of Rat Brain Membranes
- 2021576763-6781 Synthesis and Biological Characterization of Pyridohomotropanes. Structure-Activity Relationships of Conformationally Restricted Nicotinoids
- 2021576807
- 2021576808-6810 Chapter II of Surgeon General's Report
- 2021576811-6812 Background on the Cipollone Case (870900)
- 2021576813-6814
- 2021576815-6816
- 2021576817
- 2021576818-6819 Medical Center Publications
- 2021576820-6825 Acute Effects of Passive Smoking on Lung Function and Airway Reactivity in Asthmatic Subjects
- 2021576826-6828 Effects of Passive Smoking on Birth-Weight
- 2021576829-6831 Committee on Environmental Hazards Involuntary Smoking - A Hazard to Children
- Characteristic
- MARG, MARGINALIA
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- wkc58e00
Document Images
Neurobiology
CFIARACTIItIZATION OF A PURIFIID NICOTINIC RE(EP'i'OR FRIDM RAT BRAIN
USING IDIOTYPIC ANID ANTI-IDIOTYPIC ANI'IBODIES
Leo G. Abood*, John J. Langonet, Robert Bjerckefi,
* *
Xin Lu , and~Srabani Banerjee
((-)-6-hydroxymethylnicotine/affinity chromatography/
imnninoaffinity chromatography/nicotine/receptor purification)
*Center for Brain Research and Department of Biochemistry,
University of Rochester Medical Center, Rochester, NY 14642; and
tDepartments of Medicine and~ Biochemistry, Baylor College of
Medicine, Houston, TX 77030
Abbreviatione mAb, monoclonal antibody

c
I
ABSTRACT
The availability of an anti-nicotine monoclonal antibody has
made it possible to further establish the nature of the nicotine
recognition proteins purified fr= rat brain by affinity
chromatography and to provide a highly sensitive assay for
determining [3H]-nicotine binding to the purified material. An
enantiomeric analogue of nicotine, (-)-6-hydroxymethylnicotine
was used: to prepare the affinity column. In addition, with the
use of an anti-idiotypic monoclonal antibody, it was confirmed
that the recognition site for nicotine resides on a protein
complex comprised of two components with molecular weights of 62
and 57 kdalton. It was also demonstrated that the same two
proteins could be purified by immunoaffinity chromatography with
the use of an anti-idiotypic monoclonal antibody. With the use
of the anti-nicotine antibody to measure [3H]-nicotine binding,
the purified material was shown to have activity of 2.5 x 10 10
moles/mg protein. By utilizing a procedure whereby the purified
receptor protein~was conjugated to membranes via disulfide bonds,
a binding activity of 0.8 x 10 10 moles/mg was obtained. With
the availability of stereospecific monoclonal antibodies to
S-(-)-nicotine as well as monoclonal anti-idiotypic antibodies.
derived from using the anti-nicotine antibodies as immunogens,
additional procedures became available for the further
characterization of the purified nicotine receptor and examining
its (-)-[3H]-nicotine binding characteristics.
~
~
~
~
~
2 ~
W

Although the nicotinic cholinergic receptor of the Torpedo
electric organ and mammalian neuromuscular junction are similar
in their molecular characteristics (see [1] for review), the
nature of the nicotinic site in mammalian brain and its
relationship to the peripheral receptor remains problematical. A
number of studies have described limited cross-reactivity between
antibodies against the electric organ and an oo-bungarotoxin
binding site in rat brain (2-4); however, neither receptor
binding studies using [3H)-nicotine and [3H)-cholinergic as
ligands nor behavioral and electrophysiological studies indicate
any similarity in the a-bungarotoxin and nicotine sites in rat
brain. Recently, a monoclonal antibody (mAb) prepared against
purifi~ed nicotinic receptors from chick brain has been used to
isolate by immunoaffinity chromatography a nicotinic receptor
from rat brain (4). The receptor complex, which was comprised of
two proteins having molecular weights of 51 and 79 kdalton,
differs somewhat from a nicotine binding complex purified by
affinity chromatography using a nicotine analogue conjugated to
epoxysepharaose (5).
The present communication describes further studies on the
characterization of the nicotinic receptor purified by affinity
chromatography by making use of idiotypic monoclonal antibodies
(6) to nicotine as well as their anti-idiotypes.
3

MATFRIAIS AND METHODS
Preparation of Rat Brain ltieabranes. After adult male
Sprague-Dawley rats were sacrificed by spinal dislocation, the
whole brains were removed, washed, and homogenized with a
polytron in 20 volumes of ice-cold 0.05 M NaPO4, pH 7.5. The
membrane pellet obtained after centrifugation at 50,000 x g for
30 min was washed once, recentrifuged, and stored at -70°.
Solubilization of Membranes with CHAPS. The solubilization
of membranes was performed as described elsewhere (5) except that
10 mM CHAPS was substituted for 1% Triton X-100. Approximately
1 g of membrane protein in 200 ml of ice-cold 50 mM Tris.HCL, pH
7.5, containing 10 mM CHAPS + 10-3 M phenylmethanesulfonyl
fluoride + 10-3 M EGTA was homogenized with a polytron for 60 sec
(setting 5.0); and upon centrifugation of the suspension at
100,000 x g for 1 hr and concentration of the supernatant to
15 ml by flow dialysis, a final concentration of 12 mg/mL of
solubilized protein was obtained.
Affinity Chro®atography of Solubilized Membrane Extract. The
procedure for the isolation of the nicotine binding proteins by
affinity chromatography was a modification of that described
previously (5). Instead of (±)-6-(2-hydroxyethyl)nicotine,
(-)-6-hydroxymethylnicotine was used to prepare the affinity gel,
4

by conjugating 100 mg of the ligand to 5 g of epoxy activated
Sepharose in 0.02 M Na2C03, pH 10.5. Other modification involved
the use of a hydroxylapatite column (1 g in a 2 cm diameter
column) prior to the affinity column (2 cm diameter). In a
typical run, 50 mg of solubilized protein in 5 ml 0.05 M NaP04,
pH 6.5 + 10 mM CHAPS was passed through the hydroxylapatite
column,, followed by application to the affinity column. After
washing the affinity column with 40 ml of 0.05 M NaP04 buffer
containing 1 mM CHAPS, the nicotine binding protein was eluted
with 50 ml of 10-4 M(-)-nicotine inthe same buffer.
The fraction eluted from~ the affinity -column with 10-4 M
(-)-[3H]-nicotine was concentrated by flow dialysis at 40 by
repeated dilution with H20. If not used within 24 hr, the
material was lyophilized and stored at -70° until used for
further studies including NaDodSO4/polyacrylamide
electrophoresis, employing the procedure of Laemmli and Favre
(7).
Preparation of (-)-6-hydroxymethylnicotine. The preparation
of 6-hydroxymethylnicotine was based on a modification of Itokawa
et al (8), involving radical hydroxymethylation of (-)-nicotine.
To a mixture containing 0.5 g (-)-nicotine dissolved in 501 m1
methanol containing 1.7 g FeSO4.7H20 + 1 ml concentrated HZSO4 at
20° was added dropwise with~ stirring over a period of 15 min
0.7 g of 30% H202. After an additional 30 min, the solution was
5

neutralized with 10% NaOH in methanol and concentrated in vacuo
to 10 ml, 30 mL of acetone was added and the precipitate removed
by centrifugation. The acetone extract was concentrated in
vacuo, and applied to an alumina (80-200 mesh) column (2 x 5 cm),
which had been previously washed with 100 ml of benzene. After
eluting the residual (-)-nicotine with 100 ml of benzene,
6-hydroxymethylnicotine was eluted with 100 ml chloroform:
methanoltriethylamine (50:50:2). The product yield was 25% and
80% pure. Further purification (99%) was achieved by preparative
cellulose thin layer chromatography (0.5 mm thickness): using
cyclohexane as a solvent: Rf for nicotine was 0.9 and 0.0 for
(-)-6-hydroxymethylnicotine. Purity was confirmed by MS and NMt
using a standard~ provided by ,7. Seeman, Philip Morris Research~
Center.
Characterization of Anti-Nicotine Monoclonal Antibody and
Monocional Anti-Idiotype Antibody. Monoclonal anti-nicotine
402C10, an IgG2ak antibody is specific for naturally occurring
(-)-nicotine (6) and was used as immunogen for obtaining
monoclonal anti-idiotypes (9). A total of nine anti-idiotypes
were selected that inhibited the binding of fluid phase
anti-nicotine to immobilized nicotine-polylysine and were
extensively cloned, of which one, anti-idiotype 422F11, has been
extensively characterized as to ligand and receptor specificity
(9).
6

Preparation of Immumoaffinity Column with Anti-Idiotype mAb,
422F11. After 2 g cyanogen bromide-activated sepharose 4B was
washed with 100 ml 1 mM HC1 followed by 50 ml 0.1 M NaHC03 +
0.2 M NaCl, it was incubated for 2 hr with 2 mg of purified
anti-idiotypic mAb, 422F11 overnight at 4° with gentle shaking,
followed by 1 M ethanolamine for 2 hr at room temperature to
block unreacted groups. The gel was then washed with 0.1 M
NaPO4, pR 7.5, and packed into 1.5 x 4.0 mm column.
Approximately 10 mg of CHAPS-solubilized membrane protein in a
2.0 ml volume containing 1 mM CHAPS was applied to the column;
and after removing the unbound proteins with 50 m1 of 0.05 M
NaP04, pH 7.5, the receptor protein was eluted with 50 ml of
0.1 M NaP04, pH 4.0. The eluant was concentrated by flow
dialysi~s and either assayed immediately for [3H]-nicotine binding
or dialyzed, lyophilized, and stored at -70°.
Measurement of [3H]-Nicotine Binding of Conjugated Purified
Receptor. A new procedure was developed for measuring binding of
the purified proteins obtained by affinity chromatography which
involved conjugation of the material to a rat brain membrane
preparation after heat-inactivation at 90° for 15 min. To a
suspension of 10 mg/ml of heat-inactivated membranes + 10 pg of
the affinity gel-derived protein was added 0.04 ml of
0--mercaptoethanol to a final volume of 4 ml H20. After standing
7

at 200 for 2 hr, the contents were lyophilized to remove the
0-mercaptoethanol. The contents were then homogenized in 4 mL of
0.05 M Tris, pH 7.5 containing 5 x 10-3 M 2,2'-dithiopyridine.
After standing at 20°C for 2 hr, the material was dialyzed for
16 hrs at 5° against distilled H20, lyophilized, and resuspended
in 4 ml of the Tris buffer.
The procedure for measuring [3H)-nicotine binding is
described in detail elsewhere (4). Briefly, it consisted of
incubating in an i~ce-bath for 30 min a mixture containing, 0.3 ml
of the conjugated protein (representing 3 mg membrane protein +
3,og purified protein) + 1 x 10 9 M (-)-[ 3 H]-nicotine (sp. act. -
87, Ci/mmole, New England Nuclear) with or without 10-6 M
unlabeled (-)-nicotine or an analogue brought to a final volume
of 1.2 ml with 0.05 M Tris, pH 7.5 in a 2 ml polypropylene
centrifuge tube. After sedimentation in an Eppendorf centrifuge,
the tubes were washed twice with Tris (without disturbing the
pellet) and the radioactivity determined in the pellet by liquid
scintillation.
Measurement of [3H]-Nicotine Binding to Purified Receptor by
Competition with mAb 402C10. various amounts of purified
nicotine receptor (0.01-1 pg) were incubated for 1 hr at 37° in
Eppendorf centrifuge tubes in~ a final volume of 1.0 ml of a
mixture containing 0.5 ml Tris-gel buffer (0.15 M NaCl 0.01 M
Tris-HC1, pH 7.4 + 0.1% gelatin) 1 x 10 9 M (-)-[ 3 H)-nicotine at
8

vortexed, incubated overnight at 5°, and centrifuged in an
Eppendorf centrifuge for 30 min at 5°. After aspirating the
supernatant and carefully rinsing the tube with 2.0 ml of
Tri~s-gel buffer, the bottoms of the tubes were cut off and
radioactivity measured.
Measurement of Effect of Anti-Nicotine mAb and Anti-Idiotype
on [3H]-Nicotine Binding to Membranes. Various amounts of either
mAbs 402C10 were preincubated for 30 min in an ice bath with
membrane suspensions containing 2 mg protein in 1 ml 0.04 M NaP04
buffer, pH 6.5. [3HJ-nicotine binding was then determined as
described above using a final concentration of 1 x 10 9 M
[3H]-nicotine. Studies were also performed with longer
pre-incubation periods at 37° prior to measuring [3H]-nicotine
binding.
Electrophoretic Transfer of Receptor Protein from Gels to
Nitrocellulose. The procedure for the electrophoretic transfer
of the receptor proteins from polyacrylamide gels to
nitrocellulose was performed by the procedure of Towbin (10).
After the receptor proteins were separated by
NaDodSO4 polyacrylamide gel electrophoresis and the
electrophoretic blotting to nitrocellulose performed with a
Trans-Blot Cell (Bio-Rad Labs.), the nitrocellulose was immersed ©
with shaki~ng overnight at 37° in 0.05 K Tris-HC1 + 0.25 M NaC1 N
~
CA
~
9 ~
~
~
~

buffer, pH 7.4 containing 0.5% bovine serum albumin and 0.05 pg
purified 420G11, followed by incubation with biotinylated sheep
anti-mouse serum. After washing, the blots were then incubated
with avidin horseradish~peroxidase, washed, exposed to a solution
containing 5 x 10 3 M 3,3'-diamino-benzidine + 0.01% H202 in
10 mM Tris-HC1, pH 7.4, and washed in H20.
RESULTS
Fractionation of Soluble Proteins by Affinity Chromatography.
The various fractions eluted from the affinity column were
assayed for [3HJ-(-)-nicotine binding (Table 1). Approximately
one-third of the total binding activity and almost all of the
protein was present in fraction I; whereas, about two-thirds of
the total binding activity was retained by the affinity column
and eluted with 10-4 M(-)-nicotine (fraction II).
NaDodSO4-Gel Electrophoresis of Purified Receptor Proteins.
Acrylamide gel electrophoresis patterns of the receptor proteins
purified by affinity (lane B, Fig,. 1) and immunoaffinity
chromatography (lane C, Fig. 1Y were very similar, revealing a
major component with a molecular weight of about 62 kdaltons and
a minor component at 57 kdaltons. Lane D represents one-half of
a sample of the receptor eluted from the affinity column, while
lane E represents an immmoblot onto nitrocellulose on the other
half of the purified sample.
10
